326 related articles for article (PubMed ID: 24167195)
41. DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
Meyer SE; Qin T; Muench DE; Masuda K; Venkatasubramanian M; Orr E; Suarez L; Gore SD; Delwel R; Paietta E; Tallman MS; Fernandez H; Melnick A; Le Beau MM; Kogan S; Salomonis N; Figueroa ME; Grimes HL
Cancer Discov; 2016 May; 6(5):501-15. PubMed ID: 27016502
[TBL] [Abstract][Full Text] [Related]
42. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells.
Xu J; Wang YY; Dai YJ; Zhang W; Zhang WN; Xiong SM; Gu ZH; Wang KK; Zeng R; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2620-5. PubMed ID: 24497509
[TBL] [Abstract][Full Text] [Related]
43. Biologico-clinical significance of DNMT3A variants expression in acute myeloid leukemia.
Lin N; Fu W; Zhao C; Li B; Yan X; Li Y
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):270-277. PubMed ID: 29024628
[TBL] [Abstract][Full Text] [Related]
44. DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
Xu J; Zhang W; Yan XJ; Lin XQ; Li W; Mi JQ; Li JM; Zhu J; Chen Z; Chen SJ
J Hematol Oncol; 2016 Oct; 9(1):106. PubMed ID: 27724883
[TBL] [Abstract][Full Text] [Related]
45. Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.
Thol F; Winschel C; Lüdeking A; Yun H; Friesen I; Damm F; Wagner K; Krauter J; Heuser M; Ganser A
Haematologica; 2011 Dec; 96(12):1870-3. PubMed ID: 21880636
[TBL] [Abstract][Full Text] [Related]
46. A mutational and expressional analysis of DNMT3A in acute myeloid leukemia cytogenetic subgroups.
Zare-Abdollahi D; Safari S; Movafagh A; Riazi-Isfahani S; Ghadyani M; Hashemi-Gorji F; Feyzollah HG; Nasrollahi MF; Omrani MD
Hematology; 2015 Aug; 20(7):397-404. PubMed ID: 25592687
[TBL] [Abstract][Full Text] [Related]
47. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
48. CpG sites preferentially methylated by Dnmt3a in vivo.
Oka M; Rodić N; Graddy J; Chang LJ; Terada N
J Biol Chem; 2006 Apr; 281(15):9901-8. PubMed ID: 16439359
[TBL] [Abstract][Full Text] [Related]
49. The Dnmt3b splice variant is specifically expressed in in vitro-manipulated blastocysts and their derivative ES cells.
Horii T; Suetake I; Yanagisawa E; Morita S; Kimura M; Nagao Y; Imai H; Tajima S; Hatada I
J Reprod Dev; 2011 Oct; 57(5):579-85. PubMed ID: 21666347
[TBL] [Abstract][Full Text] [Related]
50. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
Que Y; Li H; Lin L; Zhu X; Xiao M; Wang Y; Zhu L; Li D
Front Immunol; 2021; 12():653030. PubMed ID: 34093541
[TBL] [Abstract][Full Text] [Related]
51. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.
Qu Y; Lennartsson A; Gaidzik VI; Deneberg S; Karimi M; Bengtzén S; Höglund M; Bullinger L; Döhner K; Lehmann S
Epigenetics; 2014 Aug; 9(8):1108-19. PubMed ID: 24866170
[TBL] [Abstract][Full Text] [Related]
52. Do mutations in DNMT3A/3B affect global DNA hypomethylation among benzene-exposed workers in Southeast China?: Effects of mutations in DNMT3A/3B on global DNA hypomethylation.
Zhang GH; Lu Y; Ji BQ; Ren JC; Sun P; Ding S; Liao X; Liao K; Liu J; Cao J; Lan Q; Rothman N; Xia ZL
Environ Mol Mutagen; 2017 Dec; 58(9):678-687. PubMed ID: 28945286
[TBL] [Abstract][Full Text] [Related]
53. Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.
Norvil AB; Petell CJ; Alabdi L; Wu L; Rossie S; Gowher H
Biochemistry; 2018 Jul; 57(29):4312-4324. PubMed ID: 27768276
[TBL] [Abstract][Full Text] [Related]
54. Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia.
Duan MY; Li M; Tian H; Tang G; Yang YC; Peng NC
Blood Cells Mol Dis; 2020 May; 82():102417. PubMed ID: 32179410
[TBL] [Abstract][Full Text] [Related]
55. Remethylation of
Ketkar S; Verdoni AM; Smith AM; Bangert CV; Leight ER; Chen DY; Brune MK; Helton NM; Hoock M; George DR; Fronick C; Fulton RS; Ramakrishnan SM; Chang GS; Petti AA; Spencer DH; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3123-3134. PubMed ID: 31996479
[TBL] [Abstract][Full Text] [Related]
56. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway.
Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
Cell Commun Signal; 2022 Oct; 20(1):168. PubMed ID: 36303144
[TBL] [Abstract][Full Text] [Related]
57. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.
Matsui T; Leung D; Miyashita H; Maksakova IA; Miyachi H; Kimura H; Tachibana M; Lorincz MC; Shinkai Y
Nature; 2010 Apr; 464(7290):927-31. PubMed ID: 20164836
[TBL] [Abstract][Full Text] [Related]
58. Germline DNMT3A mutation in familial acute myeloid leukaemia.
DiNardo CD; Beird HC; Estecio M; Hardikar S; Takahashi K; Bannon SA; Borthakur G; Jabbour E; Gumbs C; Khoury JD; Routbort M; Gong T; Kondo K; Kantarjian H; Garcia-Manero G; Chen T; Futreal PA
Epigenetics; 2021 May; 16(5):567-576. PubMed ID: 32856987
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
[TBL] [Abstract][Full Text] [Related]
60. DNMT3A
Chen D; Christopher M; Helton NM; Ferguson I; Ley TJ; Spencer DH
Blood Cancer J; 2018 Apr; 8(4):38. PubMed ID: 29618788
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
